Financing, Equity Capital Markets

Xeris Pharmaceuticals, Inc.

02/20
|
$42.7 Million
Piper Sandler served as bookrunner for Xeris Pharmaceuticals Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma